aclens.com - Acuvue Contact Lenses for Less    Shop Warby Parker Online   



Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


Contact Lenses News:

Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


SKU-O18-447 Polysoft 55 Premier from 1 800 get lens  sku

Polysoft 55 Premier - O18-447 by Ocular Sciences

Item description: This Contact Lenses Store Brands product is by Ocular Sciences - Polysoft 55 Premier is a store brand version of the Biomedics 55 Premier lens sold under an alternative name by a specific eye doctor or optical chain. These lenses are identical to Biomedics 55 Premier. All orders will be shipped as either Biomedics 55 Premier or Ultraflex 55. Note: The Ultraflex brand does not state Premier on the box, however, it does have Aspheric printed on the individual foil cover for each lens.... Learn More

Manufacturer: Ocular Sciences

Keywords: Polysoft 55 Premier Ocular Sciences Store Brands

1-800-GET-LENS

Store: We provide customers with top brands like Bausch&Lomb and Johnson&Johnson - brands that customers know and trust.

Category: Store Brands

$13.99

See the Price of Polysoft 55 Premier

You may also consider:

  Procon 55 Premier
Procon 55 Premier is a store brand version of the Biomedics 55 Premier lens sold under an alternative name by a specific eye doctor or optical chain. These lenses are identical to Biomedics 55 Premier. All orders will be shipped as either Biomedics 55 Premier or Ultraflex 55. Note: The Ultraflex brand does not state Premier on the box, however, it does have Aspheric printed on the individual foil cover for each lens. ...See The Price
 
  Proflex 55 Premier
Proflex 55 Premier is a store brand version of the Biomedics 55 Premier lens sold under an alternative name by a specific eye doctor or optical chain. These lenses are identical to Biomedics 55 Premier. All orders will be shipped as either Biomedics 55 Premier or Ultraflex 55. Note: The Ultraflex brand does not state Premier on the box, however, it does have Aspheric printed on the individual foil cover for each lens. ...See The Price
 
  Prosite 55 Premier
Prosite 55 Premier is a store brand version of the Biomedics 55 Premier lens sold under an alternative name by a specific eye doctor or optical chain. These lenses are identical to Biomedics 55 Premier. All orders will be shipped as either Biomedics 55 Premier or Ultraflex 55. Note: The Ultraflex brand does not state Premier on the box, however, it does have Aspheric printed on the individual foil cover for each lens. ...See The Price